IPO News & Commentary
Get the latest insights on new stocks
- Acute and chronic pain relief biotech Latigo Biotherapeutics files for a $100 million IPO 07/17/26
- The 2Q26 IPO Market's Law Firm Leaderboard 07/17/26
- Cancer therapies biotech BlossomHill Therapeutics files for a $100 million IPO 07/17/26
- SPAC AMR Resources Acquisition prices $250 million IPO, targeting critical minerals 07/17/26
- SPAC Phalanx Acquisition I files for a $175 million US IPO, targeting financial services 07/16/26
- Cloud computing service provider QumulusAI completes its Nasdaq direct listing 07/16/26
- Small modular reactor fuel developer Standard Nuclear prices previously downsized IPO at $15 07/16/26
See more
IPO News By Industry
- SME marketing provider Hartford Creative Group more than triples shares offered ahead of $20 million Nasdaq uplisting 06/26/26
- Canada-based content production company Ambitious Entertainment ups shares offered by 12% ahead of $18 million US IPO 06/22/26
- Hong Kong digital marketing provider Poche Technology ups shares offered by 67% ahead of $28 million US IPO 05/28/26
- US IPO Weekly Recap: Csquare and Standard Nuclear both underwhelm amid cautious market 07/17/26
- Small modular reactor fuel developer Standard Nuclear prices previously downsized IPO at $15 07/16/26
- Small modular reactor fuel developer Standard Nuclear slashes deal size by 58% ahead of $150 million IPO 07/15/26
- Coastal-focused property and casualty insurer Safepoint Holdings officially withdraws $267 million IPO 06/24/26
- US IPO Weekly Recap: Another biotech IPO pops during the short holiday week 06/18/26
- North Carolina-based bank First Carolina Financial Services prices IPO at $12.50, below the range 06/18/26
- Africa-focused mineral exploration company Chilwa Minerals files for a $6 million US IPO 07/09/26
- US IPO Weekly Recap: Bending Spoons shines in IPO, while Cumberland Farms and Jersey Mike’s join the pipeline 07/02/26
- Miner Idaho Copper raises $18 million, pricing NYSE American listing at $4.85 07/02/26
NYSE IPO News
- US IPO Week Ahead: Quiet IPO calendar primed for potential launches 07/17/26
- US IPO Weekly Recap: Csquare and Standard Nuclear both underwhelm amid cautious market 07/17/26
- Small modular reactor fuel developer Standard Nuclear prices previously downsized IPO at $15 07/16/26
- Data center operator Csquare prices IPO at $21, below the range 07/16/26
- Israel-based ocular disease biotech Tarsier Pharma ups shares offered by 11% ahead of $50 million US IPO 07/15/26
Nasdaq IPO News
- Acute and chronic pain relief biotech Latigo Biotherapeutics files for a $100 million IPO 07/17/26
- Cancer therapies biotech BlossomHill Therapeutics files for a $100 million IPO 07/17/26
- SPAC AMR Resources Acquisition prices $250 million IPO, targeting critical minerals 07/17/26
- SPAC Phalanx Acquisition I files for a $175 million US IPO, targeting financial services 07/16/26
- Cloud computing service provider QumulusAI completes its Nasdaq direct listing 07/16/26
Be the in-house IPO Expert
Our clients are focused on catalyzing growth and creating value.
Not scouring the web for IPO data.
Get the information you need in minutes, not hours. With IPO Pro, you have the entire US IPO market at your fingertips.
US IPO Week Ahead: Quiet IPO calendar primed for potential launches
No IPOs are currently scheduled for the week ahead, though a few notable names are eligible to launch. Sandwich brand Jersey Mike’s (JMKE) and convenience store chain Cumberland Farms (CMBY) are both strong candidates to join the calendar. Consumer...read more
US IPO Weekly Recap: Csquare and Standard Nuclear both underwhelm amid cautious market
Three IPOs and three SPACs priced this week. Seven IPOs and three SPACs submitted filings. This comes amid a backdrop of poor aftermarket returns from several recent listings, with SpaceX (SPCX) now below its IPO price, and SK hynix (SKHY) falling below its ...read more
Hypoxia-focused biotech NuvOx Therapeutics files for a $20 million IPO
NuvOx Therapeutics, a Phase 2 biotech developing oxygen therapeutics to treat hypoxia, filed on Friday with the SEC to raise up to $20 million in an initial public offering. The company plans to raise $20 million by offering 2.9 million shares at a price...read more